NCT01469234View on ClinicalTrials.gov

A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)

PHASE4CompletedINTERVENTIONAL

Enrollment

255

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Rhinitis

Interventions

DRUG

loratadine

loratadine, one 10 mg tablet, orally

DRUG

fexofenadine

fexofenadine, one 180 mg tablet, orally

DRUG

placebo to loratadine

one tablet, orally

DRUG

placebo to fexofenadine

one tablet, orally

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY